Key Takeaways
- Syngenta Crop Protection has signed a 5-year exclusive distribution agreement with Agrauxine by Lesaffre.
- The deal covers the private labeling and U.S. distribution of STROVEQ® and SPREXIMA® for the ornamental market.
- Both products are based on Agrauxine’s proprietary strains of Saccharomyces cerevisiae yeast.
- Syngenta continues expanding its biologicals portfolio through research and commercial partnerships.
- Leaders from both companies expressed optimism about the collaboration’s potential to broaden market access.
Syngenta Signs Distribution Agreement with Agrauxine by Lesaffre
Exclusive U.S. Deal Covers STROVEQ® and SPREXIMA® for Ornamentals
Syngenta Crop Protection has entered into a distribution agreement with Agrauxine by Lesaffre, granting Syngenta exclusive rights to private label and distribute two of Agrauxine’s proprietary biological products—STROVEQ® and SPREXIMA®—in the U.S. ornamental crop market. The agreement will run for an initial term of five years.
STROVEQ is a systemic resistance inducer (SRI), while SPREXIMA serves as a biofungicide. Both products are derived from Agrauxine’s patented strains of Saccharomyces cerevisiae yeast, known for their effectiveness in strengthening plant defense and disease prevention.
“We are extremely excited to partner with Syngenta,” said Ariel Gohlke, North American Regional Manager for Agrauxine. “This agreement is another opportunity to expand the reach of our technology. Syngenta will be an excellent partner for us to reach more markets with our unique products.”
Agrauxine by Lesaffre Products to Expand Syngenta’s Biological Portfolio
Supporting Innovation in Ornamental Plant Protection
The partnership aligns with Syngenta’s broader strategic push into biological crop protection, especially for plant and seed health. By integrating Agrauxine by Lesaffre‘s yeast-based technologies, Syngenta aims to deliver additional tools for ornamental growers to protect their crops in a preventive and sustainable manner.
“Syngenta consistently looks to bring new innovations to serve the Ornamental market,” said Carson Cashwell, Ornamental Market Manager at Syngenta. “Our partnership with Agrauxine will provide Ornamental growers with new solutions to help protect their crops while leveraging Syngenta’s existing portfolio and team.”
Agrauxine Product Overview: STROVEQ® and SPREXIMA®
Yeast-Based Biologicals for Preventive Crop Protection
Both STROVEQ and SPREXIMA utilize Agrauxine by Lesaffre‘s unique fermentation technology.
- STROVEQ works as a systemic resistance inducer, activating plant defense mechanisms prior to pathogen exposure.
- SPREXIMA is designed to protect flowers, fruit, and plant wounds from fungal infections by forming a protective barrier on the plant surface.
Commercial Terms and Market Implications
Syngenta to Distribute Through Existing U.S. Channels
Under the agreement, Syngenta will have the discretion to market and distribute both STROVEQ and SPREXIMA through its established U.S. distribution channels. The deal strengthens the companies’ ongoing collaboration and extends the reach of Agrauxine by Lesaffre technologies to more growers in the ornamental segment.
